Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| CSPG6 | RAD21 | RAD21, HR21, KIAA0078, NXP1: Double-strand-break repair protein rad21 homolog | 2.90E3 | Evidence | |||||
| CSPG6 | SMC1L1 | SMC1A, DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1: Structural maintenance of chromos | 373.0 | Evidence |
O
|
||||
| CSPG6 | XPO1 | XPO1, CRM1: Exportin-1 | 111.0 | Evidence | |||||
| CSPG6 | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 105.0 | Evidence | |||||
| CSPG6 | ANP32B | ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb | 63.00 | Evidence | |||||
| CSPG6 | SMC4L1 | SMC4, CAPC, SMC4L1: Structural maintenance of chromosomes protein 4 | 33.90 | Evidence | |||||
| CSPG6 | NAP1L1 | NAP1L1, NRP: Nucleosome assembly protein 1-like 1 | 29.50 | Evidence | |||||
| CSPG6 | SMC2L1 | SMC2, CAPE, PRO0324, SMC2L1: Structural maintenance of chromosomes protein 2 | 28.20 | Evidence | |||||
| CSPG6 | NR3C1 | NR3C1, GRL: Glucocorticoid receptor | 19.90 | Evidence | |||||
| CSPG6 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 17.80 | Evidence | |||||
| CSPG6 | BLM | BLM, RECQ2, RECQL3: Bloom syndrome protein | 17.80 | Evidence | |||||
| CSPG6 | NIPBL | N/A | 17.10 | Evidence | |||||
| CSPG6 | CCT8 | CCT8: Uncharacterized protein CCT8 | 15.10 | Evidence | O | ||||
| CSPG6 | RPL3 | RPL3, OK/SW-cl.32: 60S ribosomal protein L3 | 15.10 | Evidence | |||||
| CSPG6 | MAP3K5 | MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 | 11.80 | Evidence | |||||
| CSPG6 | KNTC2 | KNTC2, HEC, HEC1: Kinetochore protein Hec1 | 10.90 | Evidence | |||||
| CSPG6 | ATM | ATM: Serine-protein kinase ATM | 10.60 | Evidence | |||||
| CSPG6 | VAV2 | VAV2, RP11-153P4.1-003: Vav 2 oncogene | 10.20 | Evidence | |||||
| CSPG6 | TRAFD1 | TRAFD1, FLN29: TRAF-type zinc finger domain-containing protein 1 | 9.73 | Evidence | |||||
| CSPG6 | PTPN11 | N/A | 9.15 | Evidence | |||||
| CSPG6 | CCNH | CCNH: Cyclin-H | 8.72 | Evidence | |||||
| CSPG6 | MEF2D | MEF2D: Myocyte-specific enhancer factor 2D | 8.72 | Evidence | |||||
| CSPG6 | MLL | MLL, ALL1, HRX, HTRX, TRX1: Zinc finger protein HRX | 8.72 | Evidence | |||||
| CSPG6 | TRAF2 | TRAF2, TRAP3: TNF receptor-associated factor 2 | 8.24 | Evidence | |||||
| CSPG6 | EEF2 | EEF2, EF2: Elongation factor 2 | 7.4 | Evidence | O | ||||
| CSPG6 | PLK1 | PLK1, PLK: Serine/threonine-protein kinase PLK1 | 5.74 | Evidence | |||||
| CSPG6 | SMARCA2 | SMARCA2, BRM, SNF2A, SNF2L2: Probable global transcription activator SNF2L2 | 5.74 | Evidence | |||||
| CSPG6 | CHEK2 | CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 | 5.74 | Evidence | |||||
| CSPG6 | EWSR1 | EWSR1, EWS: RNA-binding protein EWS | 5.73 | Evidence | |||||
| CSPG6 | HIST1H4A | HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H | 5.29 | Evidence | |||||
| CSPG6 | POLR2A | POLR2A: Uncharacterized protein POLR2A | 4.23 | Evidence | |||||
| CSPG6 | TOPBP1 | TOPBP1, KIAA0259: DNA topoisomerase 2-binding protein 1 | 4.23 | Evidence | |||||
| CSPG6 | CREB1 | CREB1: cAMP response element-binding protein | 3.47 | Evidence | |||||
| CSPG6 | HSP90AA1 | Hsp89-alpha-delta-N | 3.04 | Evidence | |||||
| CSPG6 | RASGRP3 | RASGRP3, GRP3, KIAA0846: RAS guanyl-releasing protein 3 | 2.93 | Evidence | |||||
| CSPG6 | RPL18A | RPL18A: 60S ribosomal protein L18a | 2.51 | Evidence | |||||